Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Successful surgical management in severe hemophilia A patients using efanesoctocog alfa: A two-case experience undergoing orthopedic surgery

Francisco-Jose Lopez-Jaime, Patricia Tejuca-Gonzalez, Antonio-Jose Roberto-Bernal, Adrian Mosquera, Maria-Rosario Prieto-Bonilla

Blood (2025) 146 (Supplement 1): 6625.

https://doi.org/10.1182/blood-2025-6625

Published: 2025

Journal Articles

VTE outcomes in hemoglobinopathy patients: A propensity-matched analysis. insights from the riete registry.

Claudio Laudani, Luis Ortega-Paz, Gabriela Nathaly Bastidas Mora, Meritxell Nomdedeu, Giovanni Barillari, Benjamin Brenner, Sonia Del Pilar Otalora Valderrama, José Pedrajas, Juan José López-Núñez, Manuel Monreal

Blood (2025) 146 (Supplement 1): 2963.

https://doi.org/10.1182/blood-2025-2963

Published: 2025

Journal Articles

De novo glycosylation of MHC class I in platelets

Li Guo, Yajing Zhao, Katy Gilham, Alicia Eustes, Aaron Petrey, Scott Brakenridge, Matthew Rondina, José López

Blood (2025) 146 (Supplement 1): 1245.

https://doi.org/10.1182/blood-2025-1245

Published: 2025

Journal Articles

The exercise-induced myokine irisin acts as an endogenous anti-thrombotic agent by modulating multiple target cells

Martha Sim, Daniel Gao, Jennie Le, Jeffrey Harris, Xiaohong Wang, Yi Wang, Xiaoyun Fu, Junmei Chen, Reheman Adili, José López

Blood (2025) 146 (Supplement 1): 425.

https://doi.org/10.1182/blood-2025-425

Published: 2025

Journal Articles

NXT007 prophylaxis in people with hemophilia A with or without FVIII inhibitors: A global Phase I/II multiple-ascending-dose study

Maria Elisa Mancuso, Davide Matino, Dan Hart, Francisco-Jose Lopez-Jaime, Christophe Schmitt, Amy Shapiro, Giuliana Ventriglia, Anna Kiialainen, Laura Young, Olivier Catalani, Mark Belletrutti, Tom Chu, Jerzy Windyga, Víctor Jiménez-Yuste, Michaela Lehle, Janice Staber

Blood (2025) 146 (Supplement 1): 302.

https://doi.org/10.1182/blood-2025-302

Published: 2025

Journal Articles

P-selectin blockade effectively prevents trauma-induced microvascular obstruction

Reheman Adili, Maria Ronquillo, Nicole Roads, Hallie Lazaro, Jennifer Doan, Richard Maldonado, Junmei Chen, Dominic Chung, José López, Alexander St. John

Blood (2025) 146 (Supplement 1): 1320.

https://doi.org/10.1182/blood-2025-1320

Published: 2025

Journal Articles

Unmet Needs of Patients with Hemophilia a/B with or without Inhibitors: Real-World End-of-Study Results from the explorer6 Non-Interventional Study

Allison P. Wheeler, Aby Abraham, Chris Barnes, Renée Brown Frandsen, Kingsley Hampton, Francisco José López Jaime, Camila Martins Mazini Tavares, Keiji Nogami, Jerzy Windyga, Giancarlo Castaman

Blood (2024) 144 (Supplement 1): 2585.

https://doi.org/10.1182/blood-2024-209752

Published: 2024

Journal Articles

Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials

Anthony KC Chan, Chris Barnes, Mary Mathias, Silvia Linari, Francisco Jose Lopez Jaime, Lone Hvitfeldt Poulsen, Julien Bovet, Jan Odgaard-Jensen, Tadashi Matsushita

Blood (2023) 142 (Supplement 1): 30.

https://doi.org/10.1182/blood-2023-179739

Published: 2023

Journal Articles

Real Word Data on Levels of Emicizumab and Their Correspondence with the Global Hemostatic Capacity and the Spontaneous Joint Bleeding in Patients on Emicizumab Prophylaxis

Francisco José López Jaime, Ana Marco Rico, Ángeles Palomo Bravo, Núria Fernández-Mosteirín, María del Mar Nieto, Miguel Blanquer Blanquer, Pascual Marco Vera, Ihosvany Fernández-Bello

Blood (2023) 142 (Supplement 1): 5468.

https://doi.org/10.1182/blood-2023-188884

Published: 2023

Journal Articles

Descriptive and Epidemiological Study of Joint Damage in Non-Severe Hemophilia: Update of the Damage Study of the Mediterranean Group

Ana Marco Rico, Jose Manuel Calvo-Villas, Francisco Jose Lopez Jaime, Mariana Canaro Hinryk, Sonia Herrero-Martín, Laura Entrena Ureña, Shally Marcellini Antonio, Maria del Mar Nieto, Bolivar Diaz Jordan, Covadonga Garcia Diaz, Sergio Jurado Herrera, Faustino García Candel, Miguel Blanquer Blanquer, Pascual Marco VERA, Ihosvany Fernandez-Bello

Blood (2023) 142 (Supplement 1): 3986.

https://doi.org/10.1182/blood-2023-188412

Published: 2023

Journal Articles

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Lisa Baumann Kreuziger, Taeim Kwon, Lana Wahid, Raj S. Kasthuri, Andrei L. Kindzelski, M. Margaret Knudson, Jerry Krishnan, Gervasio Lamas, Eric Leifere, Jose Lopez-Sendon, Peter J Miller, Bela Patel, Alexandra J Weissman, John Quigley, Deborah Siegal, Tracy Y Wang, Kevin J Anstrom, Thomas L. Ortel

Blood (2023) 142 (Supplement 1): 2630.

https://doi.org/10.1182/blood-2023-190552

Published: 2023

Journal Articles

Esplorhem: Evaluation of Spanish Experience of Using Florio® Haemo Digital Medical Device for Treatment Monitoring in Hemophilia Patients. a Preliminary Report

Francisco José López-Jaime, Olga Benitez, Nuria Caballero, Rubén Berrueco, Eva Álvarez, Ihosvany Fernandez-Bello, Miguel Blanquer Blanquer, Adrián Montaño

Blood (2022) 140 (Supplement 1): 8460–8461.

https://doi.org/10.1182/blood-2022-170821

Published: 2022

Journal Articles

A Multiple Ascending Dose Study of Mim8 in Patients with Severe Hemophilia a with or without Factor VIII Inhibitors

Steven R. Lentz, Pratima Chowdary, Francisco Jose Lopez Jaime, Johnny Mahlangu, Irina Matytsina, Anne Louise Nielsen, Jerzy Windyga

Blood (2022) 140 (Supplement 1): 2735–2736.

https://doi.org/10.1182/blood-2022-160043

Published: 2022

Journal Articles

Pilot, Multicenter and Cross-Sectional Study of Joint Health in Patients with Non-Severe Hemophilia

Ihosvany Fernandez-Bello, Jose Manuel Calvo-Villas, Ana Marco, Sonia Herrero-Martín, Laura Entrena Ureña, Adrián Montaño, Francisco José López-Jaime, Bolivar Luis Diaz Jordan, Covadonga Garcia Diaz, Sergio Jurado Herrera, Noelia Pérez González, Faustino García-Candel, Miguel Blanquer Blanquer, Pascual Marco-Vera

Blood (2022) 140 (Supplement 1): 2730–2731.

https://doi.org/10.1182/blood-2022-168583

Published: 2022

Journal Articles

Esplorhem Study Design and Progress: Evaluation of Spanish Experience of Using Florio® Heamo, Digital Medical Device for Treatment Monitoring in Hemophilia Patients

Francisco José López-Jaime, Olga Benitez, Ihosvany Fernandez-Bello, Miguel Blanquer Blanquer, Adrián Montaño

Blood (2022) 140 (Supplement 1): 11312–11313.

https://doi.org/10.1182/blood-2022-170777

Published: 2022

Journal Articles

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19

Adrián Montaño, Ana Marco, Francisco José López-Jaime, Ihosvany Fernandez-Bello, Faustino García-Candel, Miguel Blanquer Blanquer, Manuel Isidro Muñoz-Pérez, Pascual Marco-Vera

Blood (2022) 140 (Supplement 1): 2778–2779.

https://doi.org/10.1182/blood-2022-166296

Published: 2022

Journal Articles

Excellent Clinical and Pharmacokinetic Real-World Experience after Switching to Rurioctocog ALFA Pegol

Olga Benitez Hidalgo, Francisco Jose Lopez Jaime, MD, María Fernanda Martínez García, MD, Juan Carlos Juarez Gimenez, PhD, Eva Alvarez Martinez, Milagros Suito, MD, Francesc Bosch, MD PhD, Mercedes Gironella Mesa

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142027

Published: 2020

Journal Articles

Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model

Jessica Morales-Ortíz, Victoria Deal, Fiorella Reyes, Gerónimo Maldonado-Martínez, Nahomy Ledesma, Franklin Staback, Cheyanne Croft, Amanda Pacheco, Humberto Ortiz-Zuazaga, C. Christian Yost, Jesse W. Rowley, Bismark Madera, Alex St. John, Junmei Chen, Jose Lopez, Matthew T. Rondina, Robert Hunter, Angelia Gibson, A. Valance Washington

Blood (2018) 132 (23): 2495–2505.

https://doi.org/10.1182/blood-2018-03-841593

Published: 2018

Includes: Supplemental data

Journal Articles

Rhabdomyosarcoma presenting with leukemic phase and massive bone marrow infiltration

Francisco J. Ortuño, María José López-Poveda

Blood (2016) 127 (26): 3458.

https://doi.org/10.1182/blood-2016-02-702316

Published: 2016

Journal Articles

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

Sarmiento Mauricio, MDPhD, Ildefonso Espigado, MD PhD, Rocio Parody, MD, Francisco Marquez, NR, Jose Falantes, MD, Teresa Caballero, PhD, Cristina Calderon, MD, Magdalena Carmona, MDPhD, Jose Lopez, MDPhD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 4363.

https://doi.org/10.1182/blood.V126.23.4363.4363

Published: 2015

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Successful surgical management in severe hemophilia A patients using efanesoctocog alfa: A two-case experience undergoing orthopedic surgery

VTE outcomes in hemoglobinopathy patients: A propensity-matched analysis. insights from the riete registry.

De novo glycosylation of MHC class I in platelets

The exercise-induced myokine irisin acts as an endogenous anti-thrombotic agent by modulating multiple target cells

NXT007 prophylaxis in people with hemophilia A with or without FVIII inhibitors: A global Phase I/II multiple-ascending-dose study

P-selectin blockade effectively prevents trauma-induced microvascular obstruction

Unmet Needs of Patients with Hemophilia a/B with or without Inhibitors: Real-World End-of-Study Results from the explorer6 Non-Interventional Study

Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials

Real Word Data on Levels of Emicizumab and Their Correspondence with the Global Hemostatic Capacity and the Spontaneous Joint Bleeding in Patients on Emicizumab Prophylaxis

Descriptive and Epidemiological Study of Joint Damage in Non-Severe Hemophilia: Update of the Damage Study of the Mediterranean Group

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Esplorhem: Evaluation of Spanish Experience of Using Florio® Haemo Digital Medical Device for Treatment Monitoring in Hemophilia Patients. a Preliminary Report

A Multiple Ascending Dose Study of Mim8 in Patients with Severe Hemophilia a with or without Factor VIII Inhibitors

Pilot, Multicenter and Cross-Sectional Study of Joint Health in Patients with Non-Severe Hemophilia

Esplorhem Study Design and Progress: Evaluation of Spanish Experience of Using Florio® Heamo, Digital Medical Device for Treatment Monitoring in Hemophilia Patients

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19

Excellent Clinical and Pharmacokinetic Real-World Experience after Switching to Rurioctocog ALFA Pegol

Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model

Rhabdomyosarcoma presenting with leukemic phase and massive bone marrow infiltration

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only